Bionano Genomics, Inc. (BNGO) shareholders
Close on Nov 17, 2026Market cap $11.21MP/E –Yield –
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Shares held by institutions
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| CVI Investments, Inc. Joint filing with Heights Capital Management, Inc. (9.90%) | 1,307,135 | 9.90% | 13G (passive) amendment | Jun 30, 2026 |
| AIGH Capital Management LLC Joint filing with Orin Hirschman (9.90%) | 1,165,000 | 9.90% | 13G (passive) | Sep 30, 2026 |
| Heights Capital Management, Inc. Joint filing with CVI Investments, Inc. (9.90%) | 1,129,411 | 9.90% | 13G (passive) amendment | Dec 31, 2025 |
| Easton Jeff Joint filing with Lind Global Fund III LP (9.35%), Lind Global Partners III LLC (9.35%) | 1,050,000 | 9.35% | 13G (passive) amendment | Dec 31, 2025 |
| Jeff Easton Joint filing with Lind Global Fund III LP (9.90%), Lind Global Partners III LLC (9.90%) | 1,005,961 | 9.90% | 13G (passive) | Sep 17, 2025 |
| Waqas Khatri Joint filing with Ayrton Capital LLC (9.99%), Alto Opportunity Master Fund, SPC - Segregated Master Portfolio B (9.99%) | 528,245 | 9.99% | 13G (passive) | Sep 30, 2025 |
| Lincoln Alternative Strategies LLC | 525,000 | 5.42% | 13G (passive) | Sep 17, 2025 |
| Lind Global Partners III LLC Joint filing with Lind Global Fund III LP (9.90%), Easton Jeff (9.90%) | 514,338 | 9.90% | 13G (passive) amendment | Sep 30, 2025 |
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of BNGO | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| Gsa Capital Partners Llp | 150,284 | 1.28% | $170.00K | −203,079 | 0.01% |
| Carret Asset Management, LLC | 125,000 | 1.06% | $141.25K | +55,000 | 0.01% |
| Geode Capital Management, LLC | 89,993 | 0.76% | $101.69K | −77,540 | 0.00% |
| Vanguard Capital Management LLC | 82,388 | 0.70% | $93.10K | +14,279 | 0.00% |
| Vanguard Fiduciary Trust Co | 51,578 | 0.44% | $58.28K | – | 0.00% |
| Renaissance Technologies LLC | 51,100 | 0.43% | $57.74K | +2,400 | 0.00% |
| Jane Street Group, LLC | 35,728 | 0.30% | $40.37K | New | 0.00% |
| Prudential Financial Inc | 31,600 | 0.27% | $35.71K | +3,600 | 0.00% |
| Northern Trust Corp | 24,561 | 0.21% | $27.75K | +4,042 | 0.00% |
| XTX Topco Ltd | 16,295 | 0.14% | $18.41K | New | 0.00% |
| Engineers Gate Manager LP | 11,988 | 0.10% | $13.55K | +135 | 0.00% |
| Hrt Financial LP | 11,740 | 0.10% | $13.00K | New | 0.00% |
| BlackRock, Inc. | 9,937 | 0.08% | $11.23K | – | 0.00% |
| Osaic Holdings, Inc. | 7,809 | 0.07% | $8.82K | +1,007 | 0.00% |
| Tower Research Capital LLC (TRC) | 5,228 | 0.04% | $5.91K | New | 0.00% |
| Morgan Stanley | 1,037 | 0.01% | $1.17K | +110 | 0.00% |
| Concord Wealth Partners | 1,000 | 0.01% | $1.13K | New | 0.00% |
| Group One Trading, L.P. | 957 | 0.01% | $1.08K | – | 0.00% |
| UBS Group AG | 812 | 0.01% | $918 | +796 | 0.00% |
| SBI Securities Co., Ltd. | 246 | 0.00% | $278 | +12 | 0.00% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | % of shares | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 33 | 1M | 6.0% | 8 / 11 | 2 / 6 | 0M | 0M |
| Q1 2026 | 31 | 1M | 7.4% | 9 / 9 | 4 / 8 | 0M | 0M |
| Q4 2025 | 31 | 1M | 7.5% | 9 / 5 | 9 / 8 | 1M | 0M |
| Q3 2025 | 31 | 0M | 2.1% | 8 / 6 | 7 / 5 | 0M | 0M |
| Q2 2025 | 28 | 0M | 0.9% | 5 / 7 | 6 / 6 | 0M | 0M |
| Q1 2025 | 30 | 0M | 0.9% | 28 / 1 | 0 / 3 | 0M | 0M |
| Q4 2024 | 5 | 0M | 0.0% | 5 / 0 | 0 / 0 | 0M | 0M |
Top mutual fund and ETF holders
Latest monthly portfolio reports (Form N-PORT)
4 funds held BNGO in Q2 2026, 39% of their shares through ETFs. Each fund counts once per quarter, from its quarter-end report.
| Fund | Shares | % of BNGO | Value | % of fund | As of |
|---|---|---|---|---|---|
| Fidelity Extended Market Index Fund | 113,564 | 0.96% | $140.82K | 0.00% | May 31, 2026 |
| Vanguard Extended Market Index Fund | 82,388 | 0.70% | $93.10K | 0.00% | Jun 30, 2026 |
| Fidelity Series Total Market Index Fund | 11,470 | 0.10% | $14.22K | 0.00% | May 31, 2026 |
| Fidelity Total Market Index Fund | 2,769 | 0.02% | $3.43K | 0.00% | May 31, 2026 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| Albert Luderer | Interim Chief Executive, Director | 8,000 | 0.07% | Sep 9, 2026 |
| R. Erik Holmlin | PRESIDENT AND CEO, Director | 1,665 | 0.01% | Feb 18, 2026 |
| Jonathan V. Dixon | General Counsel | 239 | 0.00% | Aug 5, 2026 |
| Mark Adamchak | Principal Accounting Officer | 253 | 0.00% | Aug 5, 2026 |
| Alex Reid Hastie | Chief Scientific Officer | 63 | 0.00% | Aug 5, 2026 |
| Mark Oldakowski | Chief Operating Officer | 868 | 0.01% | Aug 5, 2026 |
| Alka Chaubey | CHIEF MEDICAL OFFICER | 620 | 0.01% | Jun 3, 2026 |
| Aleksandar Rajkovic | Director | 0 | – | May 14, 2026 |
| Kristiina Vuori MD | Director | 0 | – | May 14, 2026 |
| Christopher J. Twomey | Director | 74,500 | 0.63% | May 14, 2026 |
| David L. Barker | Director | 58,364 | 0.50% | May 14, 2026 |
| Yvonne Linney | Director | 0 | – | May 14, 2026 |
| Hannah Mamuszka | Director | 65,789 | 0.56% | Jun 12, 2025 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Albert Luderer Interim Chief Executive, Director | Sep 4, 2026 | Buy | +4,000 | $1.21 | $4.84K | 8,000 |
| Albert Luderer Interim Chief Executive, Director | Aug 21, 2026 | Buy | +4,000 | $1.22 | $4.88K | 4,000 |
| Alka Chaubey CHIEF MEDICAL OFFICER | Jun 3, 2026 | Tax withholding | −24 | $1.30 | $31 | 620 |
| Mark Adamchak Principal Accounting Officer | Jun 3, 2026 | Tax withholding | −7 | $1.30 | $9 | 253 |
| Jonathan V. Dixon GENERAL COUNSEL | Jun 3, 2026 | Tax withholding | −24 | $1.30 | $31 | 239 |
| Mark Oldakowski CHIEF OPERATING OFFICER | Jun 3, 2026 | Tax withholding | −27 | $1.30 | $35 | 868 |
| Alka Chaubey CHIEF MEDICAL OFFICER | Feb 17, 2026 | Tax withholding | −18 | $1.10 | $20 | 644 |
| Mark Oldakowski CHIEF OPERATING OFFICER | Feb 17, 2026 | Tax withholding | −20 | $1.10 | $22 | 895 |
| Mark Adamchak Principal Accounting Officer | Feb 17, 2026 | Tax withholding | −3 | $1.10 | $3 | 260 |
| R. Erik Holmlin PRESIDENT AND CEO, Director | Feb 17, 2026 | Tax withholding | −51 | $1.10 | $56 | 1,657 |
| Jonathan V. Dixon GENERAL COUNSEL | Feb 17, 2026 | Tax withholding | −6 | $1.10 | $7 | 263 |
| Mark Oldakowski Chief Operating Officer | Sep 11, 2025 | Tax withholding | −59 | $4.06 | $240 | 915 |
| Alka Chaubey Chief Medical Officer | Sep 11, 2025 | Tax withholding | −51 | $4.06 | $207 | 662 |
| Mark Oldakowski Chief Operating Officer | Sep 11, 2025 | Tax withholding | −59 | $4.06 | $240 | 915 |
| Mark Oldakowski Chief Operating Officer | Jun 3, 2025 | Tax withholding | −27 | $3.69 | $100 | 974 |
| R. Erik Holmlin President and CEO, Director | Jun 3, 2025 | Tax withholding | −75 | $3.69 | $277 | 1,708 |
| Alka Chaubey Chief Medical Officer | Jun 3, 2025 | Tax withholding | −24 | $3.69 | $89 | 713 |
| Jonathan V. Dixon General Counsel | Jun 3, 2025 | Tax withholding | −25 | $3.69 | $92 | 269 |
| Mark Adamchak Principal Accounting Officer | Jun 3, 2025 | Tax withholding | −7 | $3.69 | $26 | 263 |
| R. Erik Holmlin President and CEO, Director | Mar 14, 2025 | Tax withholding | −198 | $3.47 | $687 | 1,783 |
| Mark Oldakowski Chief Operating Officer | Feb 15, 2025 | Tax withholding | −20 | $5.73 | $115 | 1,001 |
| Alka Chaubey Chief Medical Officer | Feb 15, 2025 | Tax withholding | −18 | $5.73 | $103 | 737 |
| Jonathan V. Dixon General Counsel | Feb 15, 2025 | Tax withholding | −6 | $5.73 | $34 | 294 |
| Mark Adamchak Principal Accounting Officer | Feb 15, 2025 | Tax withholding | −4 | $5.73 | $23 | 270 |
| R. Erik Holmlin President and CEO, Director | Feb 15, 2025 | Tax withholding | −51 | $5.73 | $292 | 1,981 |
| Alka Chaubey Chief Medical Officer | Sep 11, 2024 | Tax withholding | −3,075 | $0.48 | $1.48K | 45,323 |
| Mark Oldakowski Chief Operating Officer | Sep 11, 2024 | Tax withholding | −3,568 | $0.48 | $1.71K | 61,283 |
| Mark Oldakowski CHIEF OPERATING OFFICER | Jun 3, 2024 | Award | +16,000 | – | – | 64,698 |
| Jonathan V. Dixon GENERAL COUNSEL | Jun 3, 2024 | Award | +14,500 | – | – | 18,025 |
| Alka Chaubey CHIEF MEDICAL OFFICER | Jun 3, 2024 | Award | +16,000 | – | – | 48,245 |
| Gulsen Kama Chief Financial Officer | Jun 3, 2024 | Award | +16,000 | – | – | 16,000 |
| R. Erik Holmlin PRESIDENT AND CEO, Director | Jun 3, 2024 | Award | +44,000 | – | – | 121,813 |
| R. Erik Holmlin PRESIDENT AND CEO, Director | Feb 15, 2024 | Tax withholding | −3,073 | $1.27 | $3.90K | 77,663 |
| Jonathan V. Dixon GENERAL COUNSEL | Feb 15, 2024 | Tax withholding | −402 | $1.27 | $511 | 3,525 |
| Alka Chaubey CHIEF MEDICAL OFFICER | Feb 15, 2024 | Tax withholding | −1,081 | $1.27 | $1.37K | 31,487 |
| Mark Oldakowski CHIEF OPERATING OFFICER | Feb 15, 2024 | Tax withholding | −1,229 | $1.27 | $1.56K | 48,644 |
| Alka Chaubey Chief Medical Officer | Sep 18, 2023 | Award | +20,000 | – | – | 144,794 |
| Mark Oldakowski Chief Operating Officer | Sep 18, 2023 | Award | +20,000 | – | – | 317,842 |
| Hannah Mamuszka Director | Jun 13, 2023 | Buy | +65,789 | $0.76 | $50.00K | 65,789 |
| R. Erik Holmlin President and CEO, Director | May 16, 2023 | Buy | +15,000 | $0.64 | $9.60K | 806,474 |
| Mark Oldakowski Chief Operating Officer | May 12, 2023 | Tax withholding | −41,496 | $0.66 | $27.39K | 297,842 |
| R. Erik Holmlin President and CEO, Director | May 12, 2023 | Tax withholding | −50,141 | $0.66 | $33.09K | 791,474 |
| Christopher P. Stewart Chief Financial Officer | May 12, 2023 | Buy | +50,000 | $0.67 | $33.50K | 281,373 |
| Christopher P. Stewart Chief Financial Officer | Feb 15, 2023 | Award | +105,000 | – | – | 231,373 |
| Alka Chaubey Chief Medical Officer | Feb 15, 2023 | Award | +120,000 | – | – | 124,794 |
| R. Erik Holmlin President and CEO, Director | Feb 15, 2023 | Award | +300,000 | – | – | 841,615 |
| Mark Oldakowski Chief Operating Officer | Feb 15, 2023 | Award | +120,000 | – | – | 339,338 |
| Yvonne Linney Director | Aug 15, 2022 | Sale | −20,000 | $3.62 | $72.40K | 0 |
| Yvonne Linney Director | Aug 15, 2022 | Option exercise | +20,000 | $0.38 | $7.60K | 20,000 |
| David L. Barker Director | Jul 7, 2022 | Option exercise | +44,470 | $0.51 | $22.68K | 58,364 |
| David L. Barker Director | May 16, 2022 | Buy | +10,000 | $1.60 | $16.00K | 13,894 |
| Christopher P. Stewart Chief Financial Officer | May 13, 2022 | Option exercise | +60,000 | $0.56 | $33.60K | 121,579 |
| Mark Oldakowski Chief Operating Officer | May 12, 2022 | Tax withholding | −41,496 | $1.41 | $58.51K | 216,669 |
| R. Erik Holmlin President and CEO, Director | May 12, 2022 | Tax withholding | −50,141 | $1.41 | $70.70K | 538,556 |
| Soheil Shams Chief Informatics Officer | Dec 30, 2021 | Gift | −318,899 | – | – | 5,006,479 |
| R. Erik Holmlin President and CEO, Director | Nov 29, 2021 | Buy | +2,675 | $3.99 | $10.67K | 4,875 |
| R. Erik Holmlin President and CEO, Director | Nov 29, 2021 | Buy | +2,200 | $3.99 | $8.78K | 2,200 |
| R. Erik Holmlin President and CEO, Director | Nov 29, 2021 | Buy | +150 | $3.98 | $597 | 5,025 |
| Christopher P. Stewart Chief Financial Officer | Nov 19, 2021 | Option exercise | +22,500 | $0.56 | $12.60K | 55,500 |
| Soheil Shams Chief Informatics Officer | Oct 18, 2021 | Award | +5,325,378 | – | – | 5,325,378 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.
Short interest
Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)
Shares sold short, last 12 months
Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of Bionano Genomics's stock actually held short. Settlement fails (shares not delivered on time) peaked at 384,527 shares on Sep 16, 2026 over the last 90 days.
See a number that looks wrong?